PCV24 APPLICATION OF THE COST OF OBESITY MODEL FOR COST BENEFIT ANALYSIS (CBA) OF SIBUTRAMINE AND ORLISTAT- A THIRD PARTY PAYERs PERSPECTIVE
May 1, 2002, 00:00 AM
10.1016/S1098-3015(10)60938-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)60938-2/fulltext
Section Title :
Section Order :
126
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60938-2&doi=10.1016/S1098-3015(10)60938-2